Quest Diagnostics DGX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Quest Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Quest Diagnostics’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Quest Diagnostics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Quest Diagnostics's financing cash flow?
- Quest Diagnostics (DGX) reported financing cash flow of -$229M in Q2 2026.
- How has Quest Diagnostics's financing cash flow changed year-over-year?
- Quest Diagnostics's financing cash flow increased by 21.8% year-over-year, from -$293M to -$229M.
- What is the long-term trend for Quest Diagnostics's financing cash flow?
- Over 2 years (2021 to 2025), Quest Diagnostics's financing cash flow has grown at a -26.1% compound annual growth rate (CAGR), from -$2.54B to -$1.39B.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.